| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 0 % | 0 % | 0 % | 0 % | 0 % | -454 % | 8 % | 50 % | 58 % | 52 % | 54 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in ₹ | -0.06 | -0.12 | 0.22 | -0.25 | -0.42 | -0.26 | 0.22 | 0.18 | 0.20 | 0.19 | 0.20 | 0.10 |
Omkar Pharmachem
Omkar Pharmachem
0.0
-29.50
(-100.00%)
Market Cap
29.80 Cr
PE Ratio
368.75
Volume
0.00
Day High - Low
- - -
52W High-Low
30.09 - 25.50
Key Fundamentals
Market Cap
29.80 Cr
EPS
0.20
PE Ratio
368.75
PB Ratio
3.13
Book Value
9.43
EBITDA
0.30
Dividend Yield
0.00 %
Industry
Chemicals Sector
Commodity Chemicals Return on Equity
2.13
Debt to Equity
0.02
Actual
Company News
View All News
Omkar Pharmachem Limited's Board of Directors approved several key items during their meeting on August 27, 2025. The company scheduled its 30th Annual General Meeting for September 24, 2025, at Hotel Kanak in Ahmedabad at 11:30 a.m. The board appointed Mr. Anupam Kumar Mishra as Additional Non-executive Independent Director for a five-year term starting August 27, 2025, subject to shareholder approval. Mr. Mishra, aged 55 years, brings extensive experience in Management and Accountancy. The board also approved material related party transactions, appointed M/s Maulik Bhavsar & Associates as scrutinizer for the AGM voting process for financial year 2024-25, and approved the Director's report for the year ended March 31, 2025.
Omkar Pharmachem Reports Rs 2.66 Lakh Profit for Quarter Ended June 30, 2025Aug 13, 2025
Omkar Pharmachem Limited reported a profit of Rs 2.66 lakh for the quarter ended June 30, 2025, compared to a profit of Rs 4.90 lakh in the same quarter of the previous year. The company's total income remained flat at Rs 13.50 lakh, entirely from other operating income, with no revenue from net sales. Total expenses increased to Rs 9.92 lakh from Rs 8.60 lakh in the corresponding quarter last year, primarily driven by higher employee benefit expenses of Rs 4.93 lakh and other expenses of Rs 4.91 lakh. The company paid Rs 0.92 lakh in tax expenses during the quarter. The Board of Directors approved these unaudited financial results during their meeting held on August 13, 2025.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
670.80 | #1 17,089.05 | 49.42 | #1 15,112.00 | -3.79 | 354 | -228.57 | 30.56 | |
943.55 | 11,911.17 | 14.05 | 10,355.20 | 17.69 | #1 945 | -44.09 | 37.63 | |
426.15 | 6,261.88 | 10.22 | 8,393.40 | -0.07 | 586 | -7.98 | 39.25 | |
268.05 | 4,238.13 | -15.10 | 4,393.10 | 9.61 | -110 | -144.26 | 52.45 | |
450.70 | 4,143.47 | #1 8.40 | 3,271.20 | -6.51 | 624 | -37.05 | 32.01 | |
1,703.95 | 3,399.43 | 48.79 | 559.90 | 45.35 | 88 | -55.17 | 22.92 | |
430.70 | 3,163.29 | -377.69 | 4,165.00 | 6.89 | -65 | -78.57 | 35.08 | |
60.63 | 2,749.03 | 20.12 | 1,180.00 | 7.28 | 157 | -25.06 | 33.90 | |
39.01 | 2,350.58 | 4,106.00 | 35.30 | #1 11,666.67 | 1 | -25.00 | 25.41 | |
34.06 | 2,208.84 | 57.79 | 112.20 | 421.86 | 1 | #1 6,500.00 | 33.34 |
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-20.00 %
ROE
3.90 %
ROCE
-0.33 %
EBITDA Margin (Avg.)
2.12 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 9 | 10 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Other Assets | 9 | 10 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Total Equity & Liabilities | 9 | 10 | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 |
| Current Liabilities | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 | 9 |
| Reserve & Surplus | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | -1 | -1 | -1 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 |
| Investing Activities | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | -0 | 0 | -1 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 98.37 % | 98.37 % | 98.37 % | 98.37 % | 98.37 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % | 98.36 % |
| Others | 1.60 % | 1.60 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % | 1.61 % |
| No of Share Holders | 0 | 3,521 | 3,528 | 3,530 | 3,538 | 3,556 | 3,561 | 3,563 | 3,573 | 3,578 | 3,590 | 3,600 | 3,601 | 3,609 | 3,608 | 3,609 | 3,611 | 3,619 | 3,618 | 3,618 |
Announcements
Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015
Feb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Feb 16, 2026Unaudited Financial Results For The Quarter And Nine Months Ended On 31.12.2025Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2026Feb 14, 2026
Feb 14, 2026Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests From 01St January 2026 To 06Th January 2026Feb 12, 2026
Feb 12, 2026Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025Feb 04, 2026
Feb 04, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Composition Of Committees Of The Board And Change In Name Of Company Secretary And Compliance Officer Of The Company.Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2026
Jan 10, 2026Announcement Under Regulation 30- Update- Re-Lodgment Of Transfer Of Shares Request Report For The Month Of December 2025Jan 07, 2026
Jan 07, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Re-Lodgment Of Transfer Requests For The Months Of October And November 2025Dec 12, 2025
Dec 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Results- Unaudited Financial Results For September 2025Nov 14, 2025
Nov 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th November 2025Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Board Meeting Intimation For Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter And Half Yearly Ended September 30 2025Nov 06, 2025
Nov 06, 2025Report On Action Taken Under The Special Window For Re-Lodgement Of Transfer Requests For The Month Of September 2025Oct 28, 2025
Oct 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Corporate Action-Fixes Record Date For 30Th AGMAug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 202530Th AGM Scheduled To Be Held On 24Th Day Of September 2025Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 27, 2025
Aug 27, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 27Th August 2025Aug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Results- Financial Results For June 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2025Aug 13, 2025
Aug 13, 2025Board Meeting Intimation for Inter-Alia To Consider Approve And Take On Record The Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2025.Aug 05, 2025
Aug 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2025
May 29, 2025Results- Financial Results For March 31 2025May 29, 2025
May 29, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May 2025 For Approval Of Audited Financial Statements For Quarter And Year Ended On March 2025May 29, 2025
May 29, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Board Meeting Intimation for Board Meeting Intimation For Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2025May 21, 2025
May 21, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Apr 11, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Feb 15, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Financial Results For December 31 2024Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for The Board Meeting Held On 14Th February 2025 For Approval Of Unaudited Financial Results For Quarter Year Ended On 31.12.2024Feb 14, 2025
Feb 14, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results Of The Company For Quarter Ended On 31St December 2024.Feb 06, 2025
Feb 06, 2025Appointment of Company Secretary and Compliance OfficerJan 18, 2025
Jan 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Jan 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2024
Nov 13, 2024Technical Indicators
RSI(14)
Neutral 66.12
ATR(14)
Less Volatile 0.55
STOCH(9,6)
Overbought 81.64
STOCH RSI(14)
Overbought 98.07
MACD(12,26)
Bullish 0.39
ADX(14)
Strong Trend 31.57
UO(9)
Bearish 72.86
ROC(12)
Uptrend And Accelerating 14.88
WillR(14)
Overbought -5.66
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
